Rabeh El-Shesheny

InstitutionCenter of Scientific Excellence for Influenza Viruses
AddressGiza
Egypt
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 10 Covid-19 publications, with a maximum of 2 publications in March 2021 and June 2021
    All Publications
    Bar chart showing 37 publications over 12 distinct years, with a maximum of 8 publications in 2017
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. El Rifay AS, Mahmoud SH, Marouf MA, Gomaa MR, El Taweel A, Abo Shama NM, GabAllah M, Abd El Dayem SM, Kandeil A, Mostafa A, El-Shesheny R, Kayali G, Ali MA. Determinants of having severe acute respiratory syndrome coronavirus 2 neutralizing antibodies in Egypt. Influenza Other Respir Viruses. 2021 11; 15(6):750-756. PMID: 34264010.
      Citations:    Fields:    Translation:Humans
    2. Kandeil A, Mostafa A, Kutkat O, Moatasim Y, Al-Karmalawy AA, Rashad AA, Kayed AE, Kayed AE, El-Shesheny R, Kayali G, Ali MA. Bioactive Polyphenolic Compounds Showing Strong Antiviral Activities against Severe Acute Respiratory Syndrome Coronavirus 2. Pathogens. 2021 Jun 15; 10(6). PMID: 34203977.
      Citations: 12     
    3. Fayad N, Abi Habib W, Kandeil A, El-Shesheny R, Kamel MN, Mourad Y, Mokhbat J, Kayali G, Goldstein J, Abdallah J. SARS-CoV-2 Variants in Lebanon: Evolution and Current Situation. Biology (Basel). 2021 Jun 14; 10(6). PMID: 34198622.
      Citations: 1     
    4. Gomaa MR, El Rifay AS, Shehata M, Shehata M, Kandeil A, Nabil Kamel M, Marouf MA, GabAllah M, El Taweel A, Kayed AE, Kutkat O, Moatasim Y, Mahmoud SH, Abo Shama NM, El Sayes M, Mostafa A, El-Shesheny R, McKenzie PP, Webby RJ, Kayali G, Ali MA. Incidence, household transmission, and neutralizing antibody seroprevalence of Coronavirus Disease 2019 in Egypt: Results of a community-based cohort. PLoS Pathog. 2021 03; 17(3):e1009413. PMID: 33705496.
      Citations: 4     Fields:    Translation:Humans
    5. Kandeil A, Mostafa A, Hegazy RR, El-Shesheny R, El Taweel A, Gomaa MR, Shehata M, Elbaset MA, Kayed AE, Mahmoud SH, Moatasim Y, Kutkat O, Yassen NN, Shabana ME, GabAllah M, Kamel MN, Abo Shama NM, El Sayes M, Ahmed AN, Elalfy ZS, Mohamed BM, Abd El-Fattah SN, El Hariri HM, Abdel Kader M, Azmy O, Kayali G, Ali MA. Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine: Preclinical Studies. Vaccines (Basel). 2021 Mar 03; 9(3). PMID: 33802467.
      Citations: 6     
    6. Mostafa A, Kandeil A, A M M Elshaier Y, Kutkat O, Moatasim Y, Rashad AA, Shehata M, Shehata M, Gomaa MR, Mahrous N, Mahmoud SH, GabAllah M, Abbas H, Taweel AE, Kayed AE, Kamel MN, Sayes ME, Mahmoud DB, El-Shesheny R, Kayali G, Ali MA. FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2. Pharmaceuticals (Basel). 2020 Dec 04; 13(12). PMID: 33291642.
      Citations: 23     
    7. Gomaa MR, Kandeil A, Mostafa A, Roshdy WH, Kayed AE, Shehata M, Shehata M, Kutkat O, Moatasim Y, El Taweel A, Mahmoud SH, Kamel MN, Abo Shama NM, El Sayes M, El-Shesheny R, Bakheet OH, Elgohary MA, Elbadry M, Nassif NN, Ahmed SH, Abdel Messih IY, Kayali G, Ali MA. Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Antibodies in Egyptian Convalescent Plasma Donors. Front Microbiol. 2020; 11:596851. PMID: 33329484.
      Citations: 3     
    8. Kandeil A, Gomaa MR, El Taweel A, Mostafa A, Shehata M, Shehata M, Kayed AE, Kutkat O, Moatasim Y, Mahmoud SH, Kamel MN, Shama NMA, El Sayes M, El-Shesheny R, Yassien MA, Webby RJ, Kayali G, Ali MA. Common childhood vaccines do not elicit a cross-reactive antibody response against SARS-CoV-2. PLoS One. 2020; 15(10):e0241471. PMID: 33112930.
      Citations: 1     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    9. Mostafa A, Kandeil A, Shehata M, Shehata M, El Shesheny R, Samy AM, Kayali G, Ali MA. Middle East Respiratory Syndrome Coronavirus (MERS-CoV): State of the Science. Microorganisms. 2020 Jul 02; 8(7). PMID: 32630780.
      Citations: 9     
    10. Kandeil A, Mostafa A, El-Shesheny R, Shehata M, Shehata M, Roshdy WH, Ahmed SS, Gomaa M, Taweel AE, Kayed AE, Mahmoud SH, Moatasim Y, Kutkat O, Kamel MN, Mahrous N, Sayes ME, Guindy NME, Naguib A, Ali MA. Coding-Complete Genome Sequences of Two SARS-CoV-2 Isolates from Egypt. Microbiol Resour Announc. 2020 May 28; 9(22). PMID: 32467284.
      Citations: 8     
    11. Shehata MM, Kandeil A, Mostafa A, Mahmoud SH, Gomaa MR, El-Shesheny R, Webby R, Kayali G, Ali MA. A Recombinant Influenza A/H1N1 Carrying A Short Immunogenic Peptide of MERS-CoV as Bivalent Vaccine in BALB/c Mice. Pathogens. 2019 Dec 02; 8(4). PMID: 31810359.
      Citations: 2     
    12. Kandeil A, Gomaa M, Nageh A, Shehata MM, Kayed AE, Sabir JSM, Abiadh A, Jrijer J, Amr Z, Said MA, Byarugaba DK, Wabwire-Mangen F, Tugume T, Mohamed NS, Attar R, Hassan SM, Linjawi SA, Moatassim Y, Kutkat O, Mahmoud S, Bagato O, Shama NMA, El-Shesheny R, Mostafa A, Perera RA, Chu DK, Hassan N, Elsokary B, Saad A, Sobhy H, El Masry I, McKenzie PP, Webby RJ, Peiris M, Makonnen YJ, Ali MA, Kayali G. Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East. Viruses. 2019 08 05; 11(8). PMID: 31387326.
      Citations: 20     Fields:    Translation:AnimalsCellsPHPublic Health
    13. Kandeil A, Gomaa M, Shehata M, Shehata M, El-Taweel A, Kayed AE, Abiadh A, Jrijer J, Moatasim Y, Kutkat O, Bagato O, Mahmoud S, Mostafa A, El-Shesheny R, Perera RA, Ko RL, Hassan N, Elsokary B, Allal L, Saad A, Sobhy H, McKenzie PP, Webby RJ, Peiris M, Ali MA, Kayali G. Middle East respiratory syndrome coronavirus infection in non-camelid domestic mammals. Emerg Microbes Infect. 2019; 8(1):103-108. PMID: 30866764.
      Citations: 22     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    14. Ali M, El-Shesheny R, Kandeil A, Shehata M, Shehata M, Elsokary B, Gomaa M, Hassan N, El Sayed A, El-Taweel A, Sobhy H, Fasina FO, Dauphin G, El Masry I, Wolde AW, Daszak P, Miller M, VonDobschuetz S, Morzaria S, Lubroth J, Makonnen YJ. Cross-sectional surveillance of Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels and other mammals in Egypt, August 2015 to January 2016. Euro Surveill. 2017 Mar 16; 22(11). PMID: 28333616.
      Citations: 19     Fields:    Translation:AnimalsCellsPHPublic Health
    15. Ali MA, Shehata MM, Gomaa MR, Kandeil A, El-Shesheny R, Kayed AS, El-Taweel AN, Atea M, Hassan N, Bagato O, Moatasim Y, Mahmoud SH, Kutkat O, Maatouq AM, Osman A, McKenzie PP, Webby RJ, Kayali G. Systematic, active surveillance for Middle East respiratory syndrome coronavirus in camels in Egypt. Emerg Microbes Infect. 2017 Jan 04; 6(1):e1. PMID: 28050021.
      Citations: 35     Fields:    Translation:AnimalsCellsPHPublic Health
    16. Kandeil A, Shehata MM, El Shesheny R, Gomaa MR, Ali MA, Kayali G. Complete Genome Sequence of Middle East Respiratory Syndrome Coronavirus Isolated from a Dromedary Camel in Egypt. Genome Announc. 2016 Apr 28; 4(2). PMID: 27125484.
      Citations: 10     
    17. Shehata MM, Chu DK, Gomaa MR, AbiSaid M, El Shesheny R, Kandeil A, Bagato O, Chan SM, Barbour EK, Shaib HS, McKenzie PP, Webby RJ, Ali MA, Peiris M, Kayali G. Surveillance for Coronaviruses in Bats, Lebanon and Egypt, 2013-2015. Emerg Infect Dis. 2016 Jan; 22(1):148-50. PMID: 26689887.
      Citations: 7     Fields:    Translation:AnimalsCells
    18. Perera RA, Wang P, Gomaa MR, El-Shesheny R, Kandeil A, Bagato O, Siu LY, Shehata MM, Kayed AS, Moatasim Y, Li M, Poon LL, Guan Y, Webby RJ, Ali MA, Peiris JS, Kayali G. Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013. Euro Surveill. 2013 Sep 05; 18(36):pii=20574. PMID: 24079378.
      Citations: 174     Fields:    Translation:HumansAnimalsCells